Back to School: How biopharma can reboot drug development. Access exclusive analysis here

rHb1 data

SMTG (Boulder, Colo.) presented data from four Phase I studies in healthy volunteers at a

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE